DaVita Inc. (NYSE:DVA) Position Reduced by Harvest Fund Management Co. Ltd

Harvest Fund Management Co. Ltd decreased its position in shares of DaVita Inc. (NYSE:DVA) by 78.5% during the 4th quarter, Holdings Channel.com reports. The firm owned 530 shares of the company’s stock after selling 1,934 shares during the quarter. Harvest Fund Management Co. Ltd’s holdings in DaVita were worth $56,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in DVA. Hanseatic Management Services Inc. bought a new position in shares of DaVita in the third quarter valued at $36,000. GAMMA Investing LLC bought a new position in shares of DaVita in the fourth quarter valued at $60,000. FinTrust Capital Advisors LLC increased its holdings in shares of DaVita by 242.3% in the third quarter. FinTrust Capital Advisors LLC now owns 712 shares of the company’s stock valued at $67,000 after buying an additional 504 shares in the last quarter. Tacita Capital Inc bought a new position in shares of DaVita in the third quarter valued at $118,000. Finally, Federated Hermes Inc. grew its position in DaVita by 1,284.4% during the 3rd quarter. Federated Hermes Inc. now owns 1,246 shares of the company’s stock worth $118,000 after purchasing an additional 1,156 shares in the last quarter. Institutional investors own 90.12% of the company’s stock.

DaVita Stock Up 0.0 %

DaVita stock opened at $132.77 on Friday. The firm has a market cap of $11.64 billion, a price-to-earnings ratio of 17.94, a P/E/G ratio of 1.18 and a beta of 1.04. The company has a debt-to-equity ratio of 6.65, a current ratio of 1.19 and a quick ratio of 1.13. DaVita Inc. has a fifty-two week low of $71.51 and a fifty-two week high of $141.54. The firm has a fifty day moving average price of $131.89 and a two-hundred day moving average price of $110.16.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, February 13th. The company reported $1.87 EPS for the quarter, beating analysts’ consensus estimates of $1.53 by $0.34. The business had revenue of $3.15 billion during the quarter, compared to analyst estimates of $3.01 billion. DaVita had a net margin of 5.70% and a return on equity of 64.42%. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.11 earnings per share. As a group, analysts forecast that DaVita Inc. will post 9.23 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on DVA shares. StockNews.com upgraded shares of DaVita from a “buy” rating to a “strong-buy” rating in a research report on Thursday. Truist Financial boosted their price target on shares of DaVita from $130.00 to $135.00 and gave the company a “hold” rating in a report on Tuesday, February 20th. Barclays assumed coverage on shares of DaVita in a report on Wednesday, March 6th. They set an “equal weight” rating and a $133.00 price target on the stock. UBS Group upped their price objective on shares of DaVita from $113.00 to $134.00 and gave the stock a “buy” rating in a report on Wednesday, February 14th. Finally, TheStreet upgraded shares of DaVita from a “c+” rating to a “b-” rating in a report on Wednesday, February 7th. Two analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $118.50.

Insider Activity at DaVita

In related news, CEO Javier Rodriguez sold 67,603 shares of the company’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $126.11, for a total value of $8,525,414.33. Following the sale, the chief executive officer now owns 488,697 shares of the company’s stock, valued at $61,629,578.67. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, CEO Javier Rodriguez sold 67,603 shares of the company’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $126.11, for a total value of $8,525,414.33. Following the sale, the chief executive officer now owns 488,697 shares of the company’s stock, valued at $61,629,578.67. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider James O. Hearty sold 26,164 shares of the company’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $119.64, for a total transaction of $3,130,260.96. Following the sale, the insider now directly owns 20,264 shares in the company, valued at $2,424,384.96. The disclosure for this sale can be found here. Insiders have sold a total of 134,540 shares of company stock valued at $16,551,071 over the last quarter. 1.40% of the stock is owned by company insiders.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.